O
OPK
Opko Health
1.380
-0.020-1.44%Closed19:30 10/12 EDT
OPEN/PREV CLOSE1.377/1.380
TODAY RANGE1.360-1.390
VOL1.01M
MARKET CAP1.03B
52 WEEK RANGE0.9769-1.750
AVG VOL (3M)3.27M
% TURNOVER0.12%
TURNOVER0
P/E (TTM)-14.3005
% RANGE2.17%
EPS(TTM)-0.0965
P/E(FORWARD)-6.2154
P/B0.8693
BVPS1.588
DIVIDEND--
P/S1.726
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP509.60M
SHARES OUTSTANDING746.33M
NEXT EARNINGS10/27-11/02
FREE FLOAT369.27M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Cautionary Tales On Why You Should Ignore Insider Buying
Simply Wall St·10/05 05:21
OPKO Health (OPK) Sharpens Its Focus, Is It Still A Bargain?
TipRanks·10/02 20:29
Opko Health Triggers Conversion of 2029 Convertible Notes
Simply Wall St·09/23 14:33
How Investors May Respond To OPKO Health (OPK) Non Dilutive Financing
Seeking Alpha·09/18 13:22
5 Undervalued Oncology Stocks Wall Street Is Overlooking
Simply Wall St·09/16 10:21
Learn Why The Bull Case For OPKO Health (OPK) Could Change Following Royalty Backed Funding
Simply Wall St·09/14 17:23
OPKO Health (OPK) Could Be 64% Undervalued On Its $125 Million Royalty Backed Financing
Simply Wall St·09/10 20:19
OPKO Health (OPK) Stock Looks Rich As Cash Flow Risks Cloud Fair Value
Simply Wall St·08/27 00:37
What OPKO Health (OPK)'s Royalty‑Backed, Capped‑Repayment Financing Deal Means For Shareholders
NASDAQ·08/24 15:15
Here's Why You Should Retain OPK Stock in Your Portfolio for Now
Seeking Alpha·08/22 21:57
SA Asks: What are the most promising oncology companies right now?
TipRanks·08/20 16:31
Opko’s CTAP101 Pediatric Trial: A New Angle on Kidney Care Growth
Simply Wall St·08/20 15:25
OPKO Health (OPK) Stock Looks Stretched On Fresh Royalty Backed Financing
NASDAQ·08/19 16:50
OPK Raises $125 Million Against Royalties: What Investors Should Know
Same Industry
Name/Symbol
Change%
Price